Selecting endogenous promoters for improving biosynthesis of squalene in
Schizochytrium sp.
Abstract
Squalene (C30H50) is an acyclic triterpenoid compound renowned for its
myriad physiological functions, such as anticancer and antioxidative
properties, rendering it invaluable in both the food and pharmaceutical
sectors. Owing to the constraints on natural resources, microbial
fermentation has emerged as a prominent trend. Schizochytrium sp. known
to harbor the intact Mevalonate (MVA) pathway, possesses the inherent
capability to biosynthesize squalene. However, there is a dearth of
reported key genes in both the MVA pathway and the squalene synthesis
pathway, along with the associated promoter elements for their
modification. This study commenced by cloning and characterizing 13
endogenous promoters derived from transcriptome sequencing data.
Subsequently, five promoters exhibiting varying expression intensities
were chosen from the aforementioned pool to facilitate the
overexpression of the squalene synthase gene SQS, pivotal in the MVA
pathway. Ultimately, a transformed strain designated as SQS-3626,
exhibiting squalene production 2.8 times greater than that of the
wild-type strain, was identified. Lastly, the optimization of nitrogen
source concentrations and trace element contents in the fermentation
medium was conducted. Following 120 hours of fed-batch fermentation, the
accumulated final squalene yield in the transformed strain SQS-3626
reached 2.2 g/L.